Clinical trial · Observational
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
NCT05254834CI-TRIAL-00094013completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This protocol is a case-control, multicenter, diagnostic study to collect blood samples to support the development of blood-based screening tests for multiple cancers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Freenome Test | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cancer Group
- description
- Collect Subject Data Collect Blood Specimen
- interventionNames
- Diagnostic Test: Freenome Test
- label
- Non-cancer Group
- description
- Collect Subject Data Collect Blood Specimen One Year Follow Up On Cancer Status
- interventionNames
- Diagnostic Test: Freenome Test
Primary outcomes (1)
- measure
- Comparison of Blood Samples from Cancer Case and Non-cancer Control Participants
- timeFrame
- 12 months
- description
- To compare blood samples from cancer case and non-cancer control subjects in order to develop and characterize blood-based multiomics tests in specific cancer types or in a combination of multiple cancers.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
Show eligibility criteria text
Key Inclusion Criteria: * Age at least 30 years * Able and willing to provide blood samples per protocol * Able to comprehend and willing to sign and date the informed consent documents * Participants must meet one of the following: * Diagnosed with a single primary cancer that has not yet been treated * No evidence or treatment of any cancer for at least 5 years prior to enrollment Key Exclusion Criteria: * A medical condition which, in the opinion of the investigator, should preclude enrollment in the study * Known to be pregnant * Any therapy for cancer, including surgery, chemotherapy, immunotherapy, and/or radiation therapy in the 5 years preceding enrollment * Participated or currently participating in a clinical research study in which an experimental medication has been administered in the last 30 days * Participated in or currently participating in another Freenome clinical study * For the control cohort: Any previous cancer diagnosis in the 5 years preceding enrollment, or recurrence of the same primary cancer within any timeframe; or concurrent diagnosis of multiple primary cancers within any timeframe * For the cancer cohorts: Any previous cancer diagnosis in the 5 years preceding enrollment, apart from the current cancer diagnosis; OR recurrence of the same primary cancer within any timeframe; OR concurrent diagnosis of multiple primary cancers within any timeframe
References
Publications (0)
Data not yet available
No reference posted for this study.